ORGANIC
LETTERS
2000
Vol. 2, No. 4
429-431
Novel One-Step Synthesis of
Thiazolo[3,2-b]1,2,4-triazoles
Alan R. Katritzky,* Alfredo Pastor, and Michael Voronkov
Department of Chemistry, Center for Heterocyclic Compounds, UniVersity of Florida,
GainesVille, Florida 32611-7200
Peter J. Steel*
Department of Chemistry, UniVersity of Canterbury, Christchurch, New Zealand
Received November 22, 1999
ABSTRACT
Reactions of chalcones 3a−f with bis(1H-1,2,4-triazolyl) sulfoxide 4 formed the thiazolo[3,2-b]1,2,4-triazoles 5a−f, which resemble closely some
previously prepared COX-2 inhibitors. The structure of 5a was confirmed by X-ray analysis.
A recent survey1 claims that side effects of nonsteroidal
antiinflammatory drugs, such as aspirin, cause as many
deaths each year as AIDS. The development of COX-2
inhibitor drugs, known to lack these harmful side effects
while providing pain relief, has broadened the range of
therapeutic options. Thiazolotriazoles possess a broad spec-
trum of biological activities: for example 1 and 2 (R3 )
Ar) are potent and selective COX-2 inhibitors;2 2 (R3 ) H)
also exhibits pronounced antiinflammatory and analgesic
activity3 (Figure 1).
(1) Wolfe, M. M.; Lichtenstein, D. R.; Singh, G. The New England
Journal of Medicine 1999, 340, 1888.
(2) Roy, P.; Leblanc, Y.; Ball, R. G.; Brideau, C.; Chan, C. C.; Chauret,
N.; Cromlish, W.; Ethier, D.; Gauthier, J. Y.; Gordon, R.; Greig, G.; Guay,
J.; Kargman, S.; Lau, C. K.; O’Neill, G.; Silva, J.; The´rien, M.; van Staden,
C.; Wong, E.; Xu, L.; Prasit, P. Bioorg. Med. Chem. Lett. 1997, 7, 57.
(3) Pignatello, R.; Mazzone, S.; Panico, A. M.; Mazzone, G.; Pennisi,
G.; Castana, R.; Matera, M.; Blandino, G. Eur. J. Med. Chem. 1991, 26,
929.
(4) (a) Dianov, V. M.; Chikaeva, I. G.; Timirkhanova, G. A.; Strokin,
Y. V.; Zarudiy, F. S.; Lifanov, V. A. Khim.-Farm. Zh. 1994, 28, 555. (b)
Houssin, R.; Helbecque, N.; Bernier, J.-L.; Henichart, J.-P. J. Biomol. Struct.
Dyn. 1986, 4, 219. (c) O¨ hler, E.; Kang, H.-S.; Zbiral, E. Chem. Ber. 1988,
121, 977. (d) Tamura, Y.; Hayashi, H.; Saeki, E.; Kim, J.-H.; Ikeda, M. J.
Heterocycl. Chem. 1974, 11, 459.
Figure 1.
Available methods for the preparation of the heterocyclic
core of 22,4 involve multistep procedures, and some are
specific to a given substituent pattern. The most straightfor-
ward approach to 2, from the corresponding triazole-2-thiones
and aryl R-bromobenzyl derivatives, provides only the
aromatic substituents R2 and R3.2 Other methods cyclize
triazole-2-thiones with epoxyphosphonates4b or utilize
2-formamidothiazoles4d or other procedures.4a,c
(5) Katritzky, A. R.; Pastor, A.; Voronkov, M. V. J. Heterocycl. Chem.,
submitted for publication.
(6) Shephard, M. C.; Sugavanam, B.; Worthington, P. A.; Collins, D.
J.; Griffin, D. U.S. Patent 4,113,465, 1978; Chem. Abstr. 1979, 90, 82144v.
We now report a one-step preparation of thiazolo[3,2-
10.1021/ol990370w CCC: $19.00 © 2000 American Chemical Society
Published on Web 02/02/2000